National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/14/2022 release of VAERS data:

Found 4,666 cases where Vaccine is HEPA or HEPAB or HEPATYP and Serious

Government Disclaimer on use of this data



Case Details

This is page 18 out of 467

Result pages: prev   9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27   next


VAERS ID: 189063 (history)  
Form: Version 1.0  
Age: 2.0  
Sex: Male  
Location: Texas  
Vaccinated:2002-07-23
Onset:2002-07-24
   Days after vaccination:1
Submitted: 2002-07-24
   Days after onset:0
Entered: 2002-08-20
   Days after submission:27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS 536D9 / 4 LL / IM
HEPA: HEP A (HAVRIX) / GLAXOSMITHKLINE BIOLOGICALS 727A2 / 1 LL / IM
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. 0291M / 1 RL / SC

Administered by: Private       Purchased by: Private
Symptoms: Cellulitis, Injection site erythema, Injection site warmth
SMQs:, Extravasation events (injections, infusions and implants) (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: NONE
Allergies:
Diagnostic Lab Data: NONE
CDC Split Type:

Write-up: Cellulitis over left thigh with redness and warm to touch about 10.5cm to 7.5cm. Admitted 7/25/02. Treated with Keflex X 7 days and Benadryl X 2 days.


VAERS ID: 189519 (history)  
Form: Version 1.0  
Age: 5.0  
Sex: Female  
Location: Arizona  
Vaccinated:2002-04-11
Onset:2002-06-26
   Days after vaccination:76
Submitted: 2002-09-23
   Days after onset:89
Entered: 2002-08-29
   Days after submission:25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (HAVRIX) / GLAXOSMITHKLINE BIOLOGICALS 709A2 / 2 LA / IM

Administered by: Private       Purchased by: Private
Symptoms: Contusion, Epistaxis, Jaundice, Leukaemia, Pruritus, Pyrexia, Rash, Skin burning sensation
SMQs:, Cholestasis and jaundice of hepatic origin (narrow), Anaphylactic reaction (broad), Acute pancreatitis (broad), Peripheral neuropathy (broad), Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Biliary system related investigations, signs and symptoms (narrow), Biliary tract disorders (narrow), Accidents and injuries (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Haematological malignant tumours (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: UNK
Preexisting Conditions: Allergy to Keflex
Allergies:
Diagnostic Lab Data: Bone marrow biopsy on 7/18/02, result leukemia; Complete blood cell count on 7/17/02, result leukemia
CDC Split Type: A0377926A

Write-up: Report A0377926A describes leukemia in a 5 year old female who received hepatitis A vaccine inactivated (Havrix). This report was received initially from the mother of the vaccinee and has been confirmed by a physician. The vaccinee was allergic to Keflex. There were no concurrent medications. She had not experienced any adverse events following previous vaccinations. **On 4/11/02, the subject received her first injection (lot # not provided) of Havrix w/out adverse expereince, 76 days later on 6/26/02, the subject began to experience nosebleeds.** On 6/28/02, the subject received her 2nd injection of Havrix (lot VHA709A2, expiry 4/5/02). Later that day, she subject''s mother reported that the subject began to experience burning and itching sensations: the mother did not specify the location of these sensations. On 7/17/02, the subject had bruising and a rash while traveling. The mother reported, additionally that the subject had a low-grade fever "w/in one day of (the 2nd) vaccine" and jaundice w/in 3 weeks of (the 2nd) vaccine." **The reporting MD stated that a complete blood count was performed on 7/17/02 and the "results indicated leukemia." The diagnosis was confirmed by bone marrow biopsy performed on 7/18/02 (results not available to mnft''r).** The subject was hospitalized to receive chemotherapy. **The most recent info. was received on 9/17/02. The reporting MD stated** that the leukemia was possibly related to Havrix administration, but "could be coincidental w/shots". The subject''s mother thought the leukemia could have been associated w/the 2 injections of vaccine being given too closely together. Although the nosebleeds began 2 days prior to the administration of the 2nd injection of Havrix, the MD indicated the onset of of leukemia to be after the 2nd injection. He considered the leukemia to be life-threatening and disabling. As of 9/17/02, the leukemia was ongoing.


VAERS ID: 189522 (history)  
Form: Version 1.0  
Age: 68.0  
Sex: Female  
Location: Michigan  
Vaccinated:2002-08-23
Onset:2002-08-27
   Days after vaccination:4
Submitted: 2002-08-28
   Days after onset:1
Entered: 2002-08-29
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK - / IM

Administered by: Unknown       Purchased by: Unknown
Symptoms: Chills, Pyrexia, Tremor
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Parkinson-like events (broad), Noninfectious encephalopathy/delirium (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Tremendous shaking, chills, fever of 104.


VAERS ID: 189558 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Male  
Location: Colorado  
Vaccinated:2002-08-12
Onset:2002-08-12
   Days after vaccination:0
Submitted: 2002-08-14
   Days after onset:2
Entered: 2002-08-30
   Days after submission:16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 1558K / 2 LA / IM

Administered by: Public       Purchased by: Public
Symptoms: Chest discomfort, Dizziness postural, Dyspnoea, Throat tightness
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Hypersensitivity (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Keflex, Ritalin
Current Illness: Infected post-auricular cysts and ADHD
Preexisting Conditions: Possible allergy to penicillin at age 1 year old.
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: 14 year old male who developed acute onset shortness of breath, chest tightness, throat cloasing and dizziness upon standing within several hours of receiving Hep A vaccine #2 and T dose of Keflex for infected cyst.


VAERS ID: 189605 (history)  
Form: Version 1.0  
Age: 4.9  
Sex: Male  
Location: Texas  
Vaccinated:2002-08-19
Onset:2002-08-19
   Days after vaccination:0
Submitted: 2002-08-23
   Days after onset:4
Entered: 2002-09-03
   Days after submission:11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS 536C9 / UNK RA / -
HEPA: HEP A (HAVRIX) / GLAXOSMITHKLINE BIOLOGICALS 712C9 / 1 LA / -

Administered by: Public       Purchased by: Public
Symptoms: Cellulitis, Injection site erythema, Injection site oedema, Injection site pain, Injection site reaction
SMQs:, Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: NONE
Allergies:
Diagnostic Lab Data: MRI--fluid accumulation at site. 10/09/02 Add per review of medical records WBC 15.8.
CDC Split Type:

Write-up: Erythema, swelling, and pain occurring immediately after vaccine given. Pt experienced rapid increase in swelling and erythema 48 hours after vaccine given. Pt admitted and treated for cellulitis-swelling so intense that compaitment syndrome was considered. MRI performed. Clinical improvement within 48 hours of hospitalization. Symptoms essentially resolved. 10/09/02 Per review of medical records injection site reaction was diagnosis. Told to avoid Hep A vaccine in future. The folow-up states "9/3/02 symptoms reported were in the L arm, site of Hep A vaccination."


VAERS ID: 189900 (history)  
Form: Version 1.0  
Age: 27.0  
Sex: Female  
Location: Florida  
Vaccinated:2002-06-10
Onset:2002-06-10
   Days after vaccination:0
Submitted: 2002-06-27
   Days after onset:17
Entered: 2002-09-10
   Days after submission:75
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. 1480K / 1 RA / IM
HEPA: HEP A (HAVRIX) / SMITHKLINE BEECHAM 704A4 / 1 LA / IM
PPV: PNEUMO (PNEUMOVAX) / MERCK & CO. INC. 0035M / 1 LA / SC

Administered by: Public       Purchased by: Private
Symptoms: Injection site erythema, Injection site pain, Injection site warmth, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Extravasation events (injections, infusions and implants) (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Kaletra, Combivie, Mepron, amoxicillin
Current Illness:
Preexisting Conditions: Asthma, migraines, colitis, HIV+, allertgic bactrim+sustim
Allergies:
Diagnostic Lab Data:
CDC Split Type: FL02010

Write-up: P/S approx 4 hours post vacc. administration L upper arm tricep area became sore, reddened, and hot to touch states temp on 6/12/02 102.8, tx antibiotic in hosp. IV and PO.


VAERS ID: 189980 (history)  
Form: Version 1.0  
Age: 7.0  
Sex: Female  
Location: California  
Vaccinated:2002-05-05
Onset:2002-05-26
   Days after vaccination:21
Submitted: 2002-09-04
   Days after onset:101
Entered: 2002-09-11
   Days after submission:7
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 1559L / 2 LA / IM

Administered by: Private       Purchased by: Other
Symptoms: Brain stem syndrome, Headache, Hydrocephalus, Injection site inflammation, Vomiting
SMQs:, Acute pancreatitis (broad), Extravasation events (injections, infusions and implants) (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NKA
Allergies:
Diagnostic Lab Data: Head ct-08/21/02 -hydrocephalus, Head MRI -inflammation of brainstem
CDC Split Type:

Write-up: Progressively worsening vomiting which started within a few weeks of vaccine, Then developed headaches, Hospitalized in August after prolonged illness, Diagnosis unclear, Has chronic inflammatory condition of brainstem with hydrocephalus. A follow up report received 7/8/03 from a physician adds: confirmed Dx of malignant tumor of the meninges, involving pt''s brain and spinal cord. The physician goes to state that she is comfortable stating that the illness is not related to her Hepatitis A vaccine given 05/05/02. The annual follow up received on 10/1/03 states the illness was found not to be a vaccine adverse event. Please close this case, as another diagnosis was discovered and has been treated.


VAERS ID: 190186 (history)  
Form: Version 1.0  
Age: 53.0  
Sex: Female  
Location: North Carolina  
Vaccinated:2002-06-12
Onset:2002-06-12
   Days after vaccination:0
Submitted: 2002-09-04
   Days after onset:84
Entered: 2002-09-16
   Days after submission:12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPAB: HEP A + HEP B (TWINRIX) / GLAXOSMITHKLINE BIOLOGICALS 218B6 / 1 - / -

Administered by: Private       Purchased by: Private
Symptoms: Blood pressure increased, Cough, Dysphonia, Dyspnoea, Eye swelling, Flushing, Lung disorder, Pyrexia, Rash pruritic
SMQs:, Anaphylactic reaction (narrow), Angioedema (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Parkinson-like events (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Hypertension (narrow), Cardiomyopathy (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Temazepam, Mirtazapine, Bupropion hydrochloride, Semisodium valproate, Amlodipine, Lansoprazole, Thyroxine sodium, Fenofibrate, Potassium salt, Folic acid, Bupropion hydrochloride; Hydrochlorothiazide
Current Illness: Unk
Preexisting Conditions: Coughing, depression, elevated cholesterol, fatty liver, gastroesophageal reflux, hepatomegaly, hypertension, hypothyroid, multiple personality disorder, tardive dyskinesia.
Allergies:
Diagnostic Lab Data: CXR-06/12/02: "Hypoinflation and bibasilar atelectasis"
CDC Split Type: A0371557A

Write-up: Report A0371557A describes a severe allergic reaction in a 53 year old female who received hepatitis A inactivated and hepatitis B recombinant vaccine (Twinrix). The vaccinee had no known drug allergies and had not experienced any adverse events following previous vaccinations. on 6/12/02, around 11:30, the vaccinee received her first injection of Twinrix (lot HAB218B6; expiration date 12/11/03) as part of a work up for fatty liver. She was, apparently, antibody negative for hepatitis. Within on hour, the vaccinee telephoned the physician''s office and reported that she had mild shortness of breath and felt as though her face was sunburned. She reportedly attributed these symptoms to anxiety. During the telephone conversation, she reported that her face was flushed. This erythema subsequently spread to include, in sequence, the upper and lower extremities, and became pruritic. She was advised to go to the emergency room, and she started to drive herself there. A couple of blocks from the hospital, she started developing shortness of breath and a severe persistent cough. She broke out in hives, and she almost felt like she was sunburned. She did not feel that her tongue was enlarged or swollen, but did feel like there was a lump in her throat. Her voice was hoarser than normal. She was almost constantly coughing. She stated she did have a mild cough prior to this, but stated that it was much worse. She did not have any nausea or vomiting. She felt like she had some swelling around her eyes. At the emergency room, her temperature was 99 degrees F, pulse 119 beats/minute, respiratory rate 26 breaths/minute, blood pressure 194/97 mm Hg. The emergency room stated that the patient was in obvious distress. She is constantly coughing. She is congested and wheezing. She is very erythematous. She had mild per-orbital edema on examination. Examination of the lungs revealed diminished breath sounds throughout. She sounds tight. Hives with erythema were observed on her extremities, back and abdomen. Her face was erythematous. Oxygen saturation on room air was 96%. She was administered 2 liters oxygen/minute and her oxygen saturation increased to 98%. Chest x-ray taken on 6/12/02 revealed hypoinflation and bibasilar atelectasis. The emergency room physician made a diagnosis of severe allergic reaction. The vaccinee was treated with intravenous diphenhydramine 50 mg. She was observed in the emergency department for over 2.5 hours and did greatly improve. By 15:00 she was very much better. Her voice was back to normal. She was able to take sips of water. She no longer had a cough. On repeat lung examination, she still had slightly diminished breath sounds, but there was no wheezing at that time. Her lungs were much more open. She stated that she still had a mild feeling like a lump in her throat, but stated she felt this way when she gets a cold and she had begun feeling that way prior to the allergic reaction. The patient was discharged from the emergency room. She was given a prescription for prednisone and an Epipen and was told to buy over the counter benadryl and pepcid and take these through the next few days. Her symptoms resolved as of 6/12/02. The reporter stated that the allergic reactionwas not related to Twinrix; however, the Twinrix immunization series was discontinued. The vaccine provider considered the events to be life-threatening.


VAERS ID: 190414 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Female  
Location: Alaska  
Vaccinated:2002-04-24
Onset:2002-06-22
   Days after vaccination:59
Submitted: 2002-08-19
   Days after onset:58
Entered: 2002-09-20
   Days after submission:32
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (ENGERIX-B) / SMITHKLINE BEECHAM 5212B9 / 3 LA / IM
HEPA: HEP A (HAVRIX) / SMITHKLINE BEECHAM 709A2 / 2 RA / IM

Administered by: Public       Purchased by: Public
Symptoms: Asthenia, Guillain-Barre syndrome, Headache, Vomiting
SMQs:, Acute pancreatitis (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Allergies:
Diagnostic Lab Data:
CDC Split Type: AK200235

Write-up: 06/20/2002 sustained sunburn while out commercial fishing with family. 06/22/2002 went to ER with C/O HA, vomiting, weakness especially in lower extremities. MD suspected Guillain Barre. Med-vacted to another hospital. Received 5 days Immuoglobuin responded very well. Neurologist stated to mother that he felt this was due to Hep B immunization received 2 months prior. Other neurologist were not committed. Pt has fully recovered per mom. She still receives intermedient p.t. for hip weakness. The discharge summary states GBS.


VAERS ID: 191079 (history)  
Form: Version 1.0  
Age: 18.0  
Sex: Female  
Location: Missouri  
Vaccinated:2002-05-20
Onset:2002-05-20
   Days after vaccination:0
Submitted: 2002-10-21
   Days after onset:154
Entered: 2002-10-08
   Days after submission:13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. - / 1 - / IM
MEN: MENINGOCOCCAL (MENOMUNE) / SANOFI PASTEUR - / 1 - / IM

Administered by: Private       Purchased by: Private
Symptoms: Abdominal pain lower, Diarrhoea, Haematochezia, Medication error, Pyrexia, Weight decreased
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Pseudomembranous colitis (broad), Gastrointestinal haemorrhage (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (broad), Noninfectious diarrhoea (narrow), Medication errors (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Tubersol
Current Illness:
Preexisting Conditions: Medical HX: Sinusitis NOS; Concurrent Condition: Hypersensitivity NOS
Allergies:
Diagnostic Lab Data: Abdominal computed axial - 06/01/02 - negative; Body temp - 05/28/02 -intermittant low grade temperature; Stool culture - 06/01/02 - Clostridium difficile; Stool culture - 07/22/02 - Clostridium difficile toxin A & B (none detected);
CDC Split Type: WAES0208USA01869

Write-up: Information has been received from a registered nurse concerning an 18 year old white female with an allergy to sulfa and otherwise "apparently well" who on 5/20/02 was vaccinated in the left deltoid IM with a first dose of hepatitis A virus vaccine inactivated (lot 0162-invalid lot). Concomitant vaccination and therapy on 5/20/02 included a first dose of meningococcal polysaccharide vaccine (MENOMUNE) (lot UB106AA) in the left deltoid IM and a dose of tuberculin purified protein derivative (TUBERSOL) in the left forearm. Although the patient had been treated with amoxicillin trihydrate (+) clavulanate potassium (AUGMENTIN) for sinusitis from 5/7/02 until 5/17/02, there was no illness at the time of vaccination. It was reported that the patient inadvertently received 1ml of the hepatitis A virus vaccine inactivated instead of 0.5ml. This does not comply with the dosage recommendations. Subsequently, on 5/28/02 (also reported as 24 to 48 hours post vaccination), the patient experienced lower abdominal cramps and diarrhea for 3-4 days which then subsided. On 5/31/02 the patient presented to the physician''s office with bloody, mucousy diarrhea stools and abdominal pain. She had an intermittant low grade fever, no vomiting, appetite within normal limits, and not weight loss. On 6/1/02 the patient presented to the ER and was hospitalized overnight. Stool cultures were sent and the abdominal computed axial tomography was negative. On 6/4/02 the patient was diagnosed with Clostridium difficile and her therapy included metronidazole (FLAGYL), which made her quite ill, vomiting for 10 days during therapy. On 6/26/02, studies demonstrated Clostridium difficile toxin A & B and the patient received vancomycin therapy for 10 days. On 7/22/02 neither toxin was detected. On 8/26/02, it was reported that despite the negative stool culture result, the patient continues to have increased stools of 5-6 per day. She is afebrile and has lost 15 pounds but now regained 5 pounds. She is now on acidophilus and being followed by a gastroenterologist. On 9/27/02, the patient was reported as recovered by "not totally recovered yet". Follow up information received on 10/14/02 reported that the patient "still sees a gastroenterologist", with treatment of metronidazole (Flagyl)and vancomycin, for Clostridium difficile. The patient reportedly had 3-4 diarrheal stool daily when off antibiotics. a colonscopy reportedly "may be scheduled if necessary." It was reported that the patient has not recovered. Additional information has been requested.


Result pages: prev   9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=18&VAX[]=HEPA&VAX[]=HEPAB&VAX[]=HEPATYP&SERIOUS=ON


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166